| Ações de Insider | 14,039,011 shares |
Pontuação de Sentimento de Insider
A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.
É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.
Frequência de Atualização: Diariamente
Pontuação de Sentimento dos Oficiais
A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.
Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.
Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.
Frequência de Atualização: Diariamente
Principais Métricas de Insider
Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.
Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).
Número Líquido de Insiders Comprando (Classificação)
N/A
Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).
Percentual do Float Comprado por Insiders (Classificação)
N/A
Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.
Gráfico de Negociação de Insider
Ra Pharmaceuticals, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.
Roster de Insider e Métricas de Lucratividade
Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Lucro Médio (%) | Ações Possuídas |
Ajuste de Divisão |
|---|
Report errors via our new Insider Auditing Tool
Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo
Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em RARX / Ra Pharmaceuticals, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .
A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.
Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo
Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em RARX / Ra Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .
A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.
Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.
Histórico de Transações
Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.
| Arquivo Data |
Data da Operação |
Formulário | Insider | Ticker | Título de Segurança | Código | Direto | Preço de Exercício Preço Unitário |
Preço por Unidade |
Unidades Alteradas |
Valor Alterado (1K) |
Opções Restantes |
Ações Restantes |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-04-03 | 2020-04-02 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | -6,135,234 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 16.36 | -25,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Brennan Aoife | RARX | Stock Option (Right to Buy) | D | 19.88 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 48.0000 | -4,858,260 | -233,196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 22.37 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 19.88 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 9.90 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Heft Robert | RARX | Stock Option (Right to Buy) | D | 2.87 | -22,857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 19.88 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 22.37 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Stock Option (Right to Buy) | D | 9.90 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 48.0000 | -4,858,260 | -233,196 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Restricted Stock Units | D | -30,658 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 21.00 | -107,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Stock Option (Right to Buy) | D | 6.20 | -190,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | King John C | RARX | Common Stock | D | 48.0000 | -10,823 | -520 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 22.37 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 19.88 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 9.90 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | PEARSON TIMOTHY R | RARX | Stock Option (Right to Buy) | D | 2.87 | -22,857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 12.99 | -25,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Cumbo Alexander | RARX | Stock Option (Right to Buy) | D | 19.88 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10,416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 21.00 | -133,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 7.33 | -62,500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 16.64 | -90,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5.60 | -73,654 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Stock Option (Right to Buy) | D | 5.60 | -11,110 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Farzaneh-Far Ramin | RARX | Common Stock | D | 48.0000 | -14,492 | -696 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9,166 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 21.00 | -107,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 7.33 | -55,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 16.64 | -67,500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 5.60 | -25,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2.87 | -26,422 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Stock Option (Right to Buy) | D | 2.87 | -46,434 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Read Simon | RARX | Common Stock | D | 48.0000 | -12,595 | -605 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Restricted Stock Units | D | -4,375 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 21.00 | -107,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 7.33 | -26,250 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 16.64 | -60,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 5.60 | -31,428 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2.87 | -30,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 2.87 | -14,285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Stock Option (Right to Buy) | D | 0.84 | -2,857 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Ricardo Alonso | RARX | Common Stock | D | 48.0000 | -2,973 | -143 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10,416 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 21.00 | -133,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 7.33 | -62,500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 16.64 | -112,500 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 5.60 | -28,571 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2.87 | -92,283 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Stock Option (Right to Buy) | D | 2.87 | -115,572 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Lubner David Charles | RARX | Common Stock | D | 48.0000 | -15,622 | -750 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20,833 | 0 | ||||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 21.00 | -311,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 7.33 | -125,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 16.64 | -225,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 5.60 | -164,285 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2.87 | -241,460 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Stock Option (Right to Buy) | D | 2.87 | -139,371 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Treco Douglas A | RARX | Common Stock | D | 48.0000 | -234,707 | -11,266 | 0 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 22.37 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 19.88 | -15,000 | 0 | |||||
| 2020-04-03 | 2020-04-02 | 4 | Mathers Edward T | RARX | Stock Option (Right to Buy) | D | 9.90 | -15,000 | 0 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 73,654 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 11,110 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 45.1648 | -10,595 | -479 | 7,132 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 44.2500 | -2,288 | -101 | 0 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 82,860 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 12,499 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46.6116 | -10,595 | -494 | 7,132 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2020-01-21 | 2020-01-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47.0200 | -2,285 | -107 | 2,288 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 92,066 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 13,888 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46.9505 | -10,595 | -497 | 7,132 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2020-01-16 | 2020-01-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 101,272 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 15,277 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 47.2252 | -10,595 | -500 | 7,132 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 46,142 | |||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 47.0821 | -10,000 | -471 | 6,234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 47.0759 | -2,285 | -108 | 4,573 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 56,142 | |||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 46.6808 | -10,000 | -467 | 6,234 | ||||
| 2019-11-18 | 2019-11-14 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 110,478 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 16,666 | |||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46.6559 | -10,595 | -494 | 7,132 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-11-18 | 2019-11-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 119,684 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 18,055 | |||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 46.8871 | -10,595 | -497 | 7,132 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-10-17 | 2019-10-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 66,142 | |||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 46.8726 | -10,000 | -469 | 6,234 | ||||
| 2019-10-17 | 2019-10-16 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-10-17 | 2019-10-17 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 46.7000 | -2,285 | -107 | 6,858 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 76,142 | |||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 25.4050 | -10,000 | -254 | 6,234 | ||||
| 2019-09-16 | 2019-09-12 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 128,890 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 19,444 | |||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 25.2643 | -10,595 | -268 | 7,132 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-09-16 | 2019-09-16 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 27.8949 | -2,285 | -64 | 9,143 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 138,096 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 20,833 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 27.7703 | -10,595 | -294 | 7,132 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 86,142 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 27.7703 | -10,000 | -278 | 6,234 | ||||
| 2019-08-27 | 2019-08-23 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 96,142 | |||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 32.9479 | -10,000 | -329 | 6,234 | ||||
| 2019-07-18 | 2019-07-17 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 147,302 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 22,222 | |||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 33.2870 | -4,216 | -140 | 7,132 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 32.9690 | -6,379 | -210 | 11,348 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-07-16 | 2019-07-15 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-06-25 | 2019-06-21 | 4 | Ricardo Alonso | RARX | COMMON STOCK | D | 23.7248 | -2,857 | -68 | 11,428 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -9,206 | 156,508 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | Stock Options (Right to buy) | D | 5.60 | -1,389 | 23,611 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 22.0439 | -7,184 | -158 | 7,132 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21.4074 | -3,411 | -73 | 14,316 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 9,206 | 52 | 17,727 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 5.6000 | 1,389 | 8 | 8,521 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | Stock Options (Right to buy) | D | 2.87 | -10,000 | 106,142 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 23.0906 | -414 | -10 | 6,234 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 22.2103 | -9,586 | -213 | 6,648 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Read Simon | RARX | COMMON STOCK | D | 2.8700 | 10,000 | 29 | 16,234 | ||||
| 2019-06-13 | 2019-06-11 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 19.88 | 15,000 | 15,000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Heft Robert | RARX | Option to Purchase Common Stock | D | 19.88 | 15,000 | 15,000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Brennan Aoife | RARX | Option to Purchase Common Stock | D | 19.88 | 15,000 | 15,000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | PEARSON TIMOTHY R | RARX | Option to Purchase Common Stock | D | 19.88 | 15,000 | 15,000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 19.88 | 15,000 | 15,000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Shah Rajeev M. | RARX | Option to Purchase Common Stock | D | 19.88 | 15,000 | 15,000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Mathers Edward T | RARX | Option to Purchase Common Stock | D | 19.88 | 15,000 | 15,000 | |||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Restricted Stock Units | D | -15,329 | 30,658 | ||||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 21.9300 | -4,506 | -99 | 10,823 | ||||
| 2019-04-18 | 2019-04-16 | 4 | King John C | RARX | Common Stock | D | 15,329 | 15,329 | ||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28,570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28,570 | ||||||||
| 2019-03-06 | 3 | Ricardo Alonso | RARX | Common Stock | D | 28,570 | ||||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | -20,834 | 41,666 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 21.00 | 311,000 | 311,000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 21.0000 | -6,327 | -133 | 218,799 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Treco Douglas A | RARX | COMMON STOCK | D | 20,834 | 225,126 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Units | D | -10,417 | 20,833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 21.00 | 133,000 | 133,000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 21.0000 | -3,285 | -69 | 7,132 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Farzaneh-Far Ramin | RARX | COMMON STOCK | D | 10,417 | 10,417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Restricted Stock Units | D | -9,167 | 18,333 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 21.00 | 107,000 | 107,000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 21.0000 | -2,933 | -62 | 6,234 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Read Simon | RARX | COMMON STOCK | D | 9,167 | 9,167 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | -10,417 | 20,833 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 21.00 | 133,000 | 133,000 | |||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 21.0000 | -3,291 | -69 | 7,126 | ||||
| 2019-02-05 | 2019-02-01 | 4 | Lubner David Charles | RARX | COMMON STOCK | D | 10,417 | 10,417 | ||||||
| 2019-02-05 | 2019-02-01 | 4 | King John C | RARX | Options to Purchase Common Stock | D | 21.00 | 107,000 | 107,000 | |||||
| 2018-12-14 | 2018-12-12 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 15.5000 | 1,006,452 | 15,600 | 4,858,260 | ||||
| 2018-12-14 | 2018-12-14 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 15.5000 | 645,161 | 10,000 | 6,135,234 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 15.5000 | 1,006,452 | 15,600 | 4,858,260 | ||||
| 2018-11-15 | 2018-11-14 | 4 | Cumbo Alexander | RARX | Option to Purchase Common Stock | D | 12.99 | 25,000 | 25,000 | |||||
| 2018-11-01 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9.90 | 15,000 | 15,000 | |||||
| 2018-09-25 | 2018-09-21 | 4 | Brennan Aoife | RARX | Options to Purchase Common Stock | D | 16.36 | 25,000 | 25,000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Director Options to Purchase Common Stock (right to buy) | I | 9.90 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 9.90 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 9.90 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 9.90 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 9.90 | 15,000 | 15,000 | |||||
| 2018-07-02 | 2018-06-28 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 9.90 | 15,000 | 15,000 | |||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Restricted Stock Units | D | 45,987 | 45,987 | ||||||
| 2018-05-02 | 2018-05-01 | 4 | King John C | RARX | Option to Purchase Common Stock | D | 6.20 | 190,000 | 190,000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 6.0000 | 2,000,000 | 12,000 | 5,490,073 | ||||
| 2018-02-16 | 2018-02-14 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | RARX | Common Stock | I | 6.0000 | 2,500,000 | 15,000 | 3,851,808 | ||||
| 2018-02-16 | 2018-02-14 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 6.0000 | 2,500,000 | 15,000 | 3,851,808 | ||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Restricted Stock Units | D | 0.00 | 62,500 | 62,500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 7.33 | 125,000 | 125,000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Restricted Stock Units | D | 0.00 | 31,250 | 31,250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 7.33 | 62,500 | 62,500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Restricted Stock Unit | D | 0.00 | 27,500 | 27,500 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 7.33 | 55,000 | 55,000 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Restricted Stock Unit | D | 0.00 | 31,250 | 31,250 | |||||
| 2018-02-05 | 2018-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 7.33 | 62,500 | 62,500 | |||||
| 2017-10-30 | 2017-10-26 | 4 | Bisgaard Peter | RARX | Options to Purchase Common Stock | D | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Lettmann Jason | RARX | Options to Purchase Common Stock | D | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Mathers Edward T | RARX | Options to Purchase Common Stock | D | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | PEARSON TIMOTHY R | RARX | Options to Purchase Common Stock | D | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Shah Rajeev M. | RARX | Options to Purchase Common Stock | D | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | Heft Robert | RARX | Options to Purchase Common Stock | D | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-22 | 2017-06-20 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | RARX | Director Options to Purchase Common Stock (right to buy) | I | 22.37 | 15,000 | 15,000 | |||||
| 2017-06-20 | 2017-06-19 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22.0182 | -3,220 | -71 | 2,251,457 | ||||
| 2017-06-20 | 2017-06-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21.2445 | -53,200 | -1,130 | 2,254,677 | ||||
| 2017-06-12 | 2017-06-08 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22.0000 | -700 | -15 | 2,307,877 | ||||
| 2017-06-08 | 2017-06-07 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22.1073 | -4,840 | -107 | 2,308,577 | ||||
| 2017-06-08 | 2017-06-06 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 22.9806 | -7,274 | -167 | 2,313,417 | ||||
| 2017-06-06 | 2017-06-05 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23.1146 | -4,780 | -110 | 2,320,691 | ||||
| 2017-06-06 | 2017-06-02 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23.4714 | -14,867 | -349 | 2,325,471 | ||||
| 2017-06-02 | 2017-06-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23.8926 | -10,722 | -256 | 2,340,338 | ||||
| 2017-06-02 | 2017-05-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 23.9426 | -35,539 | -851 | 2,351,060 | ||||
| 2017-05-30 | 2017-05-26 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25.1448 | -5,300 | -133 | 2,386,599 | ||||
| 2017-05-30 | 2017-05-25 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25.0000 | -53 | -1 | 2,391,899 | ||||
| 2017-05-25 | 2017-05-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25.0051 | -17,451 | -436 | 2,391,952 | ||||
| 2017-05-22 | 2017-05-18 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25.4977 | -9,019 | -230 | 2,409,403 | ||||
| 2017-05-18 | 2017-05-17 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 25.5126 | -22,534 | -575 | 2,418,422 | ||||
| 2017-05-18 | 2017-05-16 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 26.3296 | -20,081 | -529 | 2,440,956 | ||||
| 2017-05-02 | 2017-03-01 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20.9126 | -7,778 | -163 | 2,461,037 | ||||
| 2017-05-02 | 2017-02-28 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20.8577 | -7,847 | -164 | 2,468,815 | ||||
| 2017-05-02 | 2017-02-27 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20.9582 | -57,844 | -1,212 | 2,476,662 | ||||
| 2017-05-02 | 2017-02-24 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 20.9336 | -5,398 | -113 | 2,534,506 | ||||
| 2017-05-02 | 2017-02-23 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21.0362 | -4,999 | -105 | 2,539,904 | ||||
| 2017-05-02 | 2017-02-22 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 21.8553 | -749 | -16 | 2,544,903 | ||||
| 2017-02-03 | 2017-02-01 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 16.64 | 112,500 | 112,500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Treco Douglas A | RARX | Options to Purchase Common Stock | D | 16.64 | 225,000 | 225,000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Farzaneh-Far Ramin | RARX | Options to Purchase Common Stock | D | 16.64 | 90,000 | 90,000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Read Simon | RARX | Options to Purchase Common Stock | D | 16.64 | 67,500 | 67,500 | |||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-2 Preferred Stock | D | -860,438 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Series B-1 Preferred Stock | D | -924,970 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 13.0000 | 246,154 | 3,200 | 2,031,562 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 860,438 | 1,785,408 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | Novo A/S | RARX | Common Stock | D | 924,970 | 924,970 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-2 Preferred Stock | D | -3,402,729 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series B-1 Preferred Stock | D | -3,657,932 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Series A Preferred Stock | D | -9,728,589 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Warrants to Purchase Common Stock | D | 0.07 | -62,914 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13.0000 | 84,615 | 1,100 | 2,545,652 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 486,104 | 2,461,037 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 522,561 | 1,974,933 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 1,389,797 | 1,452,372 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 13.0000 | -339 | -4 | 62,575 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Novartis Bioventures Ltd | RARX | Common Stock | D | 0.0700 | 62,914 | 4 | 62,914 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-2 Preferred Stock | I | -4,015,378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Series B-1 Preferred Stock | I | -4,316,531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC | RARX | Common Stock | I | 13.0000 | 161,538 | 2,100 | 1,351,808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 573,624 | 1,190,270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | RARX | Common Stock | I | 616,646 | 616,646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-2 Preferred Stock | D | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series B-1 Preferred Stock | D | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Series A Preferred Stock | D | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Warrants to Purchase Common Stock | D | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | RARX | Common Stock | D | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRETT M JAMES See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BARRIS PETER J See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | BASKETT FOREST See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KERINS PATRICK J See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | KOLLURI KRISHNA KITTU See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MOTT DAVID M See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | SANDELL SCOTT D See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Viswanathan Ravi See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-2 Preferred Stock | I | -4,362,472 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series B-1 Preferred Stock | I | -4,689,657 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Series A Preferred Stock | I | -12,447,605 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Warrants to Purchase Common Stock | I | 0.07 | -80,658 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13.0000 | 338,462 | 4,400 | 3,490,073 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 623,210 | 3,151,611 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 669,951 | 2,528,401 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 1,778,227 | 1,858,450 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 13.0000 | -435 | -6 | 80,223 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Weller Harry R See Note 2 | RARX | Common Stock | I | 0.0700 | 80,658 | 6 | 80,658 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lubner David Charles | RARX | Options to Purchase Common Stock | D | 2.87 | 29,285 | 29,285 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Series B-2 Preferred Stock | I | -4,015,378 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Series B-1 Preferred Stock | I | -4,316,531 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 13.0000 | 161,538 | 2,100 | 1,351,808 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. | RARX | Common Stock | I | 573,624 | 1,190,270 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Shah Rajeev M. See footnotes | RARX | Common Stock | I | 616,646 | 616,646 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-2 Preferred Stock | D | -3,408,439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series B-1 Preferred Stock | D | -3,664,071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Series A Preferred Stock | D | -9,744,916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Warrants to Purchase Common Stock | D | 0.07 | -63,019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13.0000 | 263,538 | 3,426 | 2,745,846 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 486,919 | 2,482,308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 523,438 | 1,995,389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 1,392,130 | 1,471,951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 13.0000 | -340 | -4 | 79,821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | MORGENTHALER VENTURE PARTNERS IX LP | RARX | Common Stock | D | 0.0700 | 63,019 | 4 | 80,161 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -481,503 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3,533,875 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -517,617 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3,798,914 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-2 Preferred Stock | I | -3,408,439 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series B-1 Preferred Stock | I | -3,664,071 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Series A Preferred Stock | I | -9,744,916 | 0 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Warrants to Purchase Common Stock | I | 0.07 | -63,019 | 0 | |||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13.0000 | 15,633 | 203 | 4,066,503 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13.0000 | 114,752 | 1,492 | 4,050,870 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13.0000 | 263,538 | 3,426 | 3,936,118 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 68,786 | 3,672,580 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 504,839 | 3,603,794 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 73,945 | 3,098,955 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 542,702 | 3,025,010 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 486,919 | 2,482,308 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 523,438 | 1,995,389 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 1,392,130 | 1,471,951 | ||||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 13.0000 | -340 | -4 | 79,821 | ||||
| 2016-10-31 | 2016-10-31 | 4 | Lettmann Jason | RARX | Common Stock | I | 0.0700 | 63,019 | 4 | 80,161 | ||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34,284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34,284 | ||||||||
| 2016-10-25 | 3 | Morgenthaler Management Partners IX, LLC | RARX | Common Stock | D | 34,284 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408,584 | ||||||||
| 2016-10-25 | 3 | Treco Douglas A | RARX | Common Stock | D | 408,584 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34,284 | ||||||||
| 2016-10-25 | 3 | Lettmann Jason See footnotes | RARX | Common Stock | I | 34,284 |
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
